CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 67 enrolled
Drug / intervention
EBUS TBNA of mediastinal lesions or lymph nodesprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02690610
NCT02690610N/ACompleted

Value of Rapid on Site Evaluation During Endobronchial Ultrasound Guided Trans-bronchial Needle Aspiration (EBUS-TBNA) in the Diagnosis of Mediastinal Lesions

Tanta University·interventional·Posted Feb 24, 2016·Updated Apr 25, 2018

In Brief

A clinical study evaluating EBUS TBNA of mediastinal lesions or lymph nodes for Mediastinum. Completed, enrolled 67 participants across 1 site.

Detailed Summary

This prospective study will include 30 patients with hilar/mediastinal lymph nodes detected by thoracic CT either there was a known lung malignancy (for staging purpose) or not (for diagnosing purpose). All patients will undergo to ROSE during EBUS-guided TBNA. Mediastinoscopy or other invasive procedures will be performed if EBUS-guided TBNA doesn't provide representative material.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMediastinum
CountriesEgypt
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedFeb 24, 2016
Enrollment StartNov 1, 2015
Primary CompletionMay 1, 2016
Study CompletionSep 1, 2016
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 10.4 years ago

Interventions

EBUS TBNA of mediastinal lesions or lymph nodesprocedure

Through endo-bronchial ultrasound, a transbronchial needle will be introduced to take biopsies from mediastinal lesions under ultrasonic guidance.